New 250GB Plans LIVE now. See plans →
All posts
May 27, 2026 · Operations

Reviewing Clinical Trial Video Footage Without Breaching Patient Consent Terms

How CROs and device companies can review clinical trial video footage while staying inside informed-consent scope and restricting access to named study staff.

RK
Rohit K.
Creative Operations Writer, PlayPause
Operations

A CRO we talked to last year had a problem that had nothing to do with the trial data itself. The endpoints were clean, the statistics were solid, and the FDA submission was on track, but somewhere between a site coordinator's laptop and a sponsor's shared drive, raw procedure footage of a patient undergoing a device implant had ended up in a Dropbox folder that three people outside the study roster could open. Nobody stole anything. Nobody meant harm. It was just a file that got forwarded because forwarding a file is the easiest thing in the world to do, and that's exactly the problem with how most trial teams still handle video.

Clinical trial video, whether it's a surgical procedure recording, a device-in-use demonstration, or footage captured for a training module built from real patient encounters, sits in a strange spot. It's not quite the same as a lab result or a case report form, but it's absolutely covered by the same informed consent scope, and it carries visual and audio identifiers that a spreadsheet never will. A face. A voice. A room number visible in the background. So when we say a review workflow needs to respect consent scope, we mean something very specific: the footage should only ever be visible to the exact list of people the patient agreed could see it, for the exact purpose they agreed to, and not one person more, not one purpose more.

Most informed consent documents for trials involving video capture spell out who reviews the footage (the study team, specific monitors, sometimes a core imaging lab) and what it's used for (safety review, endpoint adjudication, occasionally training if the patient separately opted in). What they don't say is "and also whoever happens to have access to the shared drive where this gets uploaded," but that's functionally what happens when a CRO defaults to generic file sharing tools built for marketing teams and ad agencies, not regulated healthcare data.

Consent scope is not a suggestion

If your access list doesn't mirror your IRB-approved personnel roster exactly, you're already outside the terms the patient agreed to, regardless of intent.

We built our review workflow around named-user access specifically because "the whole team has the link" is not an access control model, it's a hope. A workspace should let you name exactly who is on it, tie every login to a real identity, and remove someone the moment their role on the study ends, whether that's a monitor rotating off or a site coordinator who left the institution. That's a very different posture from a shareable link that keeps working for anyone who has it, forever, which is how footage ends up somewhere it was never supposed to be in the first place.

Multi-Site Trials Multiply the Problem

A single-site study is hard enough to keep straight, but most trials that involve video capture today run across a dozen or more sites simultaneously, and each site has its own coordinator, its own investigator, and its own local habits around how footage gets uploaded and shared before it ever reaches the sponsor. We've seen sites default to whatever their institution's IT department happens to already support, a hospital's internal file server in one case, a coordinator's personal cloud account in another, and the sponsor only finds out which tool was actually used when something goes wrong. A centralized workspace that every site is required to use, rather than one that every site is merely encouraged to use, is really the only way to keep the access list consistent across a trial that might enroll patients in twelve different cities under twelve different local IT setups.

What "Named Study Personnel Only" Actually Requires

Saying the review tool should restrict access to named study personnel sounds simple until you map out who that actually includes on a real multi-site trial.

1Site coordinators upload raw procedure footage tied to a subject ID
2Principal investigators and sub-investigators review for protocol deviations
3CRO monitors cross-check footage against the case report form
4Sponsor safety reviewers see only the segments relevant to an adverse event
5Core lab reviewers get read-only access scoped to their adjudication task

Every one of those roles needs a different level of access, and most generic sharing tools give you exactly two options, anyone with the link or nobody at all. Neither is what a trial needs. What you actually want is a workspace where a sponsor safety reviewer can be added to one specific project folder tied to one site, without also getting visibility into every other site's footage, and where you can prove, months later during an audit, exactly who that person was and when they looked.

The Subject-ID Problem

A detail that trips up teams constantly: video files get named things like "patient_room3_procedure.mov" instead of being tied to a coded subject ID, which means the file itself becomes an identifier that has to be handled under the same de-identification discipline as any other trial document. We tell CRO teams to treat every uploaded clip like a source document, filed under project structure that mirrors the protocol, not a loose folder of media that anyone with upload rights can rename or move around.

73%
of clinical trials now capture some form of video or imaging data
4-6
average number of external review roles per multi-site trial
21 CFR Part 11
the regulation most CROs are already building toward for e-records

Version Control Isn't Optional When Footage Gets Re-Cut

Here's the part people miss: it's rarely the raw footage alone that leaks, it's the derivative. A training clip gets pulled from a longer procedure recording, a highlight reel gets built for an internal safety briefing, a device manufacturer wants a shorter cut for a regulatory submission. Each of those touches the original consent scope again, and each one needs its own access list, its own version history, and its own record of who approved the final cut before it went anywhere. If your review tool treats every re-edit as a brand new unmanaged file, you've lost the thread connecting it back to the original consent terms, and that's exactly the kind of gap an auditor will find in about thirty seconds. We've seen this play out with a device manufacturer that needed a ninety-second cut of a longer implant procedure recording for a regulatory submission, and because the original two-hour file and the derivative ninety-second cut lived in the same versioned project rather than as two separate uploads with no relationship recorded between them, the sponsor could show exactly which frames made the final submission and trace that cut back to the source recording and its original consent scope without anyone having to reconstruct the chain from memory six months later.

Shared drive plus email thread

nobody can say for certain who has actually opened the file, versions get renamed and re-uploaded with no history, and access doesn't expire when a role ends

A dedicated review workspace with named access

every viewer is a real identity tied to a role, every version is timestamped and linked to the one before it, and access can be revoked the moment a study role changes

Review_Cut_v4.mp4In Review
212160p · ProRes
00:34 / 02:18
SR
Sarah 0:34

Frame-accurate note, everyone sees the exact same thing.

In PlayPause, every comment is pinned to the exact frame, no more “which part?” email threads.

Building the Audit Trail Your Sponsor Will Ask For

Sooner or later, whether it's an FDA inspection, a sponsor audit, or just internal QA before submission, someone is going to ask you to prove that footage of a specific patient was only ever seen by people authorized to see it. If you can't produce that record cleanly, you're in a much worse position than if the footage had simply never been reviewed at all, because now you can't demonstrate compliance either way. This is exactly the kind of requirement we cover in more depth in what compliance officers should require from a video review tool's audit log, and the short version is that viewer identity, timestamp, and access duration all need to be logged automatically, not reconstructed from memory after the fact.

An access list you have to reconstruct after the fact isn't an access list, it's a guess.

Where PlayPause Fits Into This

We didn't design PlayPause for clinical trials specifically, but the core of what we built, flat per-workspace pricing so a CRO doesn't pay per reviewer seat, named-user access instead of open links, frame-accurate timecoded comments so a monitor can flag the exact second a deviation occurs, and full version history on every uploaded cut, ends up mapping onto trial review needs almost exactly. A study team can spin up a project per protocol, add only the reviewers named for that site, and know that when a video gets re-cut for a safety briefing, the new version is logged right alongside the original, not floating around as a separate untracked file. If you handle video anywhere near a regulated setting, it's also worth reading about how we approach sharing security more broadly, since a lot of the same controls apply whether the footage is a patient procedure or a corporate deposition.

  • Named-user access instead of shareable links
  • Automatic timestamp and viewer logging on every open
  • Version history tied to the original upload
  • Project-level isolation so one site's footage never leaks into another's workspace
  • Flat pricing so adding a compliance reviewer doesn't blow the budget

Compare that to the workarounds most CROs are still running, which usually means a mix of a general-purpose file host, a spreadsheet tracking who's supposed to have access, and a lot of trust that nobody forwards anything. That trust gets tested constantly, and the teams we talk to who've had a near-miss, not a breach exactly, just a file that ended up somewhere it shouldn't have, are usually the ones who come looking for something more structured afterward. Sound familiar. If you've ever had to explain to a sponsor why you're not sure who saw a piece of footage, you know exactly the position we're describing, and it's not one you want to be in twice.

Getting Your Workflow Ready Before the Next Site Activation

The fix here isn't complicated, it's just a matter of setting up the workspace correctly before footage starts flowing rather than trying to retrofit access controls after three sites are already uploading to a shared drive. Map your consent-approved personnel roster to workspace roles before the first patient is enrolled, keep every project isolated by protocol and site, and make sure whatever tool you're using logs access automatically instead of relying on someone to write it down. According to Statista, the volume of digital health data, video included, has grown fast enough that most CROs' internal processes for handling it haven't fully caught up, which is exactly the gap teams fall into when a study scales past one site.

It's also worth thinking about this the same way legal teams think about chain of custody for sensitive recordings, a topic we go into further in how law firms share body cam and surveillance footage with outside counsel securely, because the underlying principle, that access should be provable and reversible, is identical whether the footage came from a hospital procedure room or a police vehicle.

What to Do Before Your Next Protocol Kicks Off

If your trial involves any video capture at all, whether it's procedure footage, device demonstrations, or patient interviews, it's worth looking at PlayPause pricing and seeing how a per-workspace model compares to what you're paying per seat right now on a general file-sharing tool. Set up your project structure, name your reviewers, and get the audit trail running before the footage starts coming in rather than after. Reach out via Contact PlayPause if you want to talk through how a specific protocol's review chain would map onto named-user projects before your next site activation, and we'll walk you through it directly.

RK
Rohit K.
Creative Operations Writer, PlayPause

Rohit K. writes about creative operations for PlayPause. He focuses on how agencies and production teams run review and approval at scale without scope creep, missed deadlines, or version chaos.

Related resources

Keep reading

Bring your team into one review space

Centralize feedback, lock approvals, and deliver faster, start free today.

Sign Up for Free